Table of contents

Rheumatoid arthritis

• Original research: Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis (25 February, 2020)

  Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, Tsu-Yi Hsieh, Yi-Ming Chen, Josef S Smolen, Gerd Burmester, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao, Mark C Genovese
• Review: Measuring ACPA in the general population or primary care: is it useful? (19 February, 2020)

  Axel Finckh, Delphine Courvoisier, Celine Lamacchia
• Original research: Prognosis of pneumonia in patients with rheumatoid arthritis: the role of medication and disease activity prior to admission a population-based cohort study (10 February, 2020)

  Mette Holland-Fischer, Reimar W Thomsen, Ulrik Tarp, Mette Nørgaard
• Original research:

  ​Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment

  (15 January, 2020)

  Annette de Thurah, Ina Trolle Andersen, Andreas Bugge Tinggaard, Anders Hammerich Riis, Josephine Therkildsen, Hans Erik Bøtker, Morthen Bøttcher, Ellen-Margrethe Hauge
• Original research: Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis (14 January, 2020)

  Josef S Smolen, Jung-Yoon Choe, Michael E Weinblatt, Paul Emery, Edward Keystone, Mark C Genovese, Gihyun Myung, Evelyn Hong, Inyoung Baek, Jeehoon Ghil
• Review: Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis (7 January, 2020)

  Przemysław Błyszczuk, Zoltan Szekanecz
• Original article: Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study (7 January, 2020)

  Alain Saraux, René-Marc Flipo, Francis Fagnani, Jacques Massol, Gabrielle Cukierman, Jean-Michel Joubert, Philippe Huot-Marchand, Bernard Combe
• Review: Glucocorticoids in rheumatoid arthritis: current status and future studies (7 January, 2020)

  Charlotte Hua, Frank Buttgereit, Bernard Combe
• Original research: Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies (5 May, 2020)

  Mark C Genovese, Herbert Kellner, Yasumasa Arai, Rafael Muniz, Rieke Alten
• Original research: Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison (5 May, 2020)

  B Fautrel, B Zhu, P C Taylor, M van de Laar, P Emery, F De Leonardis, C L Kannowski, C Nicolay, Z Kadziola, I De La Torre, R Fleischmann
• Original research: One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment (5 May, 2020)

  Kristien Van der Elst, Patrick Verschueren, Diederik De Cock, An De Groef, Veerle Stouten, Sofia Pazmino, Johanna Vriezekolk, Johan Joly, Philip Moons, René Westhovens
• Original research: Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers (5 May, 2020)

  Nathalie Carrier, Artur J de Brum-Fernandes, Patrick Liang, Ariel Masetto, Sophie Roux, Norma K Biln, Walter P Maksymowych, Gilles Boire
• Review: Management of Fatigue in Rheumatoid Arthritis (7 May, 2020)

  Janet E Pope
• Original article: Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland (7 May, 2020)

  A Finckh, C Tellenbach, L Herzog, A Scherer, B Moeller, A Ciurea, I von Muehlenen, C Gabay, D Kyburz, L Brulhart, R Müller, P Hasler, P Zufferey
• Original article: DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability (10 May, 2020)

  M Verstappen, E van Mulligen, P H P de Jong, A H M van der Helm-Van Mil
• Original research: Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study (18 May, 2020)

  Helga Westerlind, Bénédicte Delcoigne, Johan Askling
• Original research: Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity? (29 May, 2020)

  Sytske Anne Bergstra, Joy A Van Der Pol, Naghmeh Riyazi, Yvonne P M Goekoop-Ruiterman, Pit J S M Kerstens, Willem Lems, Tom W J Huizinga, Cornelia F Allaart